NM_000051.4:c.*3136A>G

Variant names:

• chr11-108368644-A-G
• rs3092845
• NM_000051.4:c.*3136A>G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_Strong BS1_Supporting BS2

The NM_000051.4(ATM):​c.*3136A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00229 in 217,468 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

• Frequency:
  • Genomes: 𝑓 0.0024 (3 hom., cov: 32)
  • Exomes 𝑓: 0.0020 (0 hom.)
• Consequence: ATM NM_000051.4 3_prime_UTR
• Clinical Significance: Uncertain significance criteria provided, single submitter U:1
• Conservation: PhyloP100: -1.04
• Publications: 3 publications found

Genes affected

ATM (HGNC:795): (ATM serine/threonine kinase) The protein encoded by this gene belongs to the PI3/PI4-kinase family. This protein is an important cell cycle checkpoint kinase that phosphorylates; thus, it functions as a regulator of a wide variety of downstream proteins, including tumor suppressor proteins p53 and BRCA1, checkpoint kinase CHK2, checkpoint proteins RAD17 and RAD9, and DNA repair protein NBS1. This protein and the closely related kinase ATR are thought to be master controllers of cell cycle checkpoint signaling pathways that are required for cell response to DNA damage and for genome stability. Mutations in this gene are associated with ataxia telangiectasia, an autosomal recessive disorder. [provided by RefSeq, Aug 2010]

C11orf65 (HGNC:28519): (chromosome 11 open reading frame 65) Predicted to be involved in negative regulation of mitochondrial fission and negative regulation of protein targeting to mitochondrion. Predicted to be located in cytosol and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]

ACMG classification

Our verdict: Benign. The variant received -9 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.92).
• BS1: Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00241 (367/152354) while in subpopulation NFE AF = 0.00284 (193/68040). AF 95% confidence interval is 0.00251. There are 3 homozygotes in GnomAd4. There are 183 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
• BS2: High Homozygotes in GnomAd4 at 3 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000051.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	ATM	NM_000051.4	MANE Select	c.*3136A>G		3_prime_UTR	Exon 63 of 63	NP_000042.3
	ATM	NM_001351834.2		c.*3136A>G		3_prime_UTR	Exon 64 of 64	NP_001338763.1
	C11orf65	NM_001330368.2		c.640+17276T>C		intron	N/A	NP_001317297.1

Ensembl Transcripts

Selected	Gene	Transcript	Tags	HGVSc	HGVSp	Effect	Exon Rank	Protein	UniProt
	ATM	ENST00000675843.1	MANE Select	c.*3136A>G		3_prime_UTR	Exon 63 of 63	ENSP00000501606.1
	ATM	ENST00000452508.7	TSL:1	c.*3136A>G		3_prime_UTR	Exon 64 of 64	ENSP00000388058.2
	C11orf65	ENST00000615746.4	TSL:1	c.*2-12535T>C		intron	N/A	ENSP00000483537.1

Frequencies

GnomAD3 genomes AF: 0.00240 AC: 366 AN: 152236 Hom.: 3 Cov.: 32

Gnomad AFR AF: 0.000362

Gnomad AMI AF: 0.0329

Gnomad AMR AF: 0.00105

Gnomad ASJ AF: 0.000288

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.00207

Gnomad FIN AF: 0.00885

Gnomad MID AF: 0.00949

Gnomad NFE AF: 0.00284

Gnomad OTH AF: 0.00192

GnomAD4 exome AF: 0.00203 AC: 132 AN: 65114 Hom.: 0 Cov.: 0 AF XY: 0.00219 AC XY: 66 AN XY: 30176

African (AFR) AF: 0.000990 AC: 3 AN: 3030

American (AMR) AF: 0.00 AC: 0 AN: 1976

Ashkenazi Jewish (ASJ) AF: 0.00 AC: 0 AN: 4116

East Asian (EAS) AF: 0.00 AC: 0 AN: 9472

South Asian (SAS) AF: 0.00551 AC: 3 AN: 544

European-Finnish (FIN) AF: 0.00 AC: 0 AN: 42

Middle Eastern (MID) AF: 0.00256 AC: 1 AN: 390

European-Non Finnish (NFE) AF: 0.00282 AC: 113 AN: 40082

Other (OTH) AF: 0.00220 AC: 12 AN: 5462

GnomAD4 genome AF: 0.00241 AC: 367 AN: 152354 Hom.: 3 Cov.: 32 AF XY: 0.00246 AC XY: 183 AN XY: 74502

African (AFR) AF: 0.000361 AC: 15 AN: 41586

American (AMR) AF: 0.00105 AC: 16 AN: 15300

Ashkenazi Jewish (ASJ) AF: 0.000288 AC: 1 AN: 3472

East Asian (EAS) AF: 0.00 AC: 0 AN: 5186

South Asian (SAS) AF: 0.00228 AC: 11 AN: 4832

European-Finnish (FIN) AF: 0.00885 AC: 94 AN: 10622

Middle Eastern (MID) AF: 0.0102 AC: 3 AN: 294

European-Non Finnish (NFE) AF: 0.00284 AC: 193 AN: 68040

Other (OTH) AF: 0.00190 AC: 4 AN: 2110

Alfa AF: 0.00286 Hom.: 0

Bravo AF: 0.00203

Asia WGS AF: 0.000866 AC: 3 AN: 3478

ClinVar

ClinVar submissions as Germline

Significance: Uncertain significance

Revision: criteria provided, single submitter

Pathogenic	VUS	Benign	Condition
-	1	-	Ataxia-telangiectasia syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.92
CADD	Benign	1.1
DANN	Benign	0.54
PhyloP100		-1.0
Mutation Taster		=100/0	polymorphism

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Other links and lift over

dbSNP: rs3092845; hg19: chr11-108239371; COSMIC: COSV107217431;